What You Should Know:
- Ypsomed and Sidekick Health today announced a collaboration to extend Ypsomed’s device and SmartServices offering by implementing a self-injection module in Sidekick’s proven digital therapeutics solution.
- The combination of Ypsomed’s devices with Sidekick’s digital health, behavioural economics and gamification expertise will form a unique solution delivering an engaging and personalized patient experience to people with chronic conditions, as well as a turn-key,
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Pharmacogenomics: The Key to Unlocking the Future of Personalized Healthcare
Pharmacogenomics—the study of genetic influences on an individual's response to therapeutic medications—is an area of personalized medicine that is gaining momentum. Although pharmacogenomics has been around for a while, providers, health plans, pharmacists and legislators are developing a greater appreciation for its potential benefits and applications.
How Can Pharmacogenomics Improve Outcomes?
By considering a person’s DNA in treatment options, providers can determine how an
Read More
Syapse and Genesis Research Form RWE Partnership in Oncology
What You Should Know:
- Today, Syapse, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases, announced that they have entered into a strategic partnership with Genesis Research.
- This partnership will focus on conducting real-world evidence-based research that supports the development and launch of new and innovative treatments.
- As part of the
Read More
Intelerad Acquires PenRad Technologies
What You Should Know:
- Today, Intelerad, a leading global provider of enterprise medical imaging solutions, announced its acquisition of PenRad, a software provider for enhancing productivity for breast imaging and lung screening.
- The acquisition expands Intelerad’s product offerings for mammography and lung analytics, ensuring radiologists, technologists and other healthcare professionals can drive greater productivity and meet higher oncology screening demand, while improving patient
Read More
What is the Potential for Digital Twins in Healthcare?
Digital twins are virtual representations of an object or system that spans its lifecycle, is updated from real-time data, and use simulation, machine learning and reasoning to help decision-making (IBM). In most cases, this helps data scientists understand how products are operating in production environments and anticipate how they may behave overtime. But what happens when a digital twin is that of a human being?
By using digital twins to model a person, you can use technologies like
Read More
GSA Renews Contract with Xenex LightStrike Germ-Zapping Robots
What You Should Know:
- Xenex Disinfection Services has announced the 5-year renewal of its U.S. General Services Administration (GSA) contract, which enables federal agencies (including Veterans Affairs and U.S. Department of Defense healthcare facilities) to easily deploy Xenex’s powerful LightStrike™ room disinfection technology.
- In addition to federal agencies, the GSA contract supports the procurement needs of eligible state, local, territorial, and tribal governments (including
Read More
Annexus Health Raises $33M to Optimize Patient Access and Affordability
What You Should Know:
- Annexus Health, Inc. has announced its Series B financing of $33 million, which was led by leading digital health growth equity firm Transformation Capital.
- The funding is set to advance Annexus Health's mission to improve access to care and combat patient financial toxicity amid ever-rising healthcare costs
Re-Imagining the Healthcare Ecosystem by Increasing Access To Care
Annexus Health strives for a better healthcare experience for patients, more
Read More
Elevation Oncology Secures $50M Loan Facility with K2 HealthVentures
What You Should Know:
Elevation Oncology, a clinical-stage biopharmaceutical company focused on the development of precision oncology products for patients with genomically defined cancers, today announced that it has secured a $50M senior secured loan facility from funds managed by K2 HealthVentures.
Elevation plans to use the funding from the facility will primarily support the exclusive license of EO-3021 (SYSA1801) outside of Greater China from CSPC Pharmaceutical Group and the
Read More
Syapse Raises $35M to Expand Learning Health Network
What You Should Know:
- Syapse raises $35M led by an affiliate of Innovatus Capital Partners, LLC (Innovatus)to tackle the challenge of understanding, preventing, and treating complex cancers.
- The investment will allow Syapse to expand its artificial intelligence and machine learning capabilities, making it more efficient to uncover meaningful insights from real-world oncology data.
Syapse, a San Francisco, CA-based real-world evidence company accelerating the
Read More
RefleXion Medical Raises $125M for Biology-Guided Radiotherapy
What You Should Know:
- RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, today announced the closing of a $125M debt facility, of which $55M is available immediately to repay the company’s existing $50M of debt.
- The remaining $70M of the new facility will be made available upon reaching certain regulatory and commercial milestones. The funds will support the continued commercialization of the RefleXion X1
Read More
